Latest Observability News

Westgold Resources has unveiled a maiden Mineral Resource Estimate of 2.3 million ounces of gold at its Fletcher Zone, effectively doubling the Beta Hunt mine’s resource base and setting the stage for expanded production.

Shift4 Payments, LLC has entered into a definitive scheme implementation agreement to acquire Smartpay Holdings Limited at NZ$1.20 per share, subject to regulatory and shareholder approvals. The transaction outlines a detailed timetable and conditions, including Overseas Investment Office consent and court sanction.

Waterco Limited has disclosed a historical breach of ASX Listing Rule 10.1 involving lease agreements with a related party, prompting plans to seek retrospective shareholder approval at its 2025 AGM.

Kingsrose Mining announces the immediate resignation of Managing Director Fabian Baker and appoints industry veteran Terry Holohan as Acting CEO to steer its Scandinavian projects and acquisition strategy.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

Neurizon Therapeutics reveals that its lead drug candidate NUZ-001 and its metabolite effectively penetrate the blood-brain barrier and reverse pathological protein aggregation linked to ALS, marking a critical step forward in neurodegenerative disease treatment.

Pivotal Metals has clarified the cause behind its recent share price surge, attributing it to a publicly released research note while confirming no undisclosed material information.

Anson Resources has completed integrated static and dynamic geological models for its Green River Lithium Project, revealing a large, interconnected lithium brine reservoir and setting the stage for expanded resource drilling.

Singular Health Group has inked a $1.3 million contract with Provider Network Solutions to deploy its 3DICOM imaging platform across key US states, backed by an $8 million capital raise to fuel national expansion.

Legacy Minerals has completed its inaugural drilling campaign at the Thomson Project in north-west NSW, intersecting extensive quartz-sulphide veins indicative of promising intrusion-related gold and copper mineralisation. Assay results are pending, with further drilling approvals underway to explore additional targets.

Race Oncology has successfully dosed the first patient with its RC220 and doxorubicin combination in a Phase 1 trial for advanced solid tumours, reporting no dose-limiting side effects. This milestone marks a key step in evaluating the safety and potential cardioprotective benefits of the novel therapy.

Euro Manganese has signed a non-binding term sheet with UK-based Integrals Power to supply high-purity manganese sulphate for next-generation LMFP battery cathodes, aiming to strengthen sustainable battery supply chains.